scholarly journals Current Drug Therapy in Chronic Heart Failure: the New Guidelines of the European Society of Cardiology (ESC)

2017 ◽  
Vol 47 (5) ◽  
pp. 543 ◽  
Author(s):  
Dominik Berliner ◽  
Johann Bauersachs
Keyword(s):  
Heart Failure ◽  
Drug Therapy ◽  
Chronic Heart Failure ◽  
European Society ◽  
Current Drug ◽  
New Guidelines ◽  
European Society Of Cardiology

scholarly journals Újdonságok a krónikus szívelégtelenség gyógyszeres terápiájában

2016 ◽  
Vol 157 (38) ◽  
pp. 1517-1521
Author(s):  
Noémi Nyolczas
Keyword(s):  
Heart Failure ◽  
Clinical Trials ◽  
Chronic Heart Failure ◽  
European Society ◽  
Pharmacological Treatment ◽  
Pharmacological Therapy ◽  
Diagnosis And Treatment ◽  
Current State ◽  
New Guidelines ◽  
European Society Of Cardiology

Recently, results of several novel clinical trials on the pharmacological treatment of chronic heart failure have been published. In addition, the new European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure and a focused update by the ACC/AHA/HFSA on new pharmacological therapy for heart failure has been reported in 2016. This paper intends to provide an overview of the current state of the pharmacological treatment of chronic heart failure in the light of the new guidelines which incorporate the results of the new clinical trials. Orv. Hetil., 2016, 157(38), 1517–1521.

scholarly journals 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

2021 ◽  
pp. 22-25
Author(s):  
Natasha Meunier-McVey
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
European Society ◽  
Diagnosis And Treatment ◽  
University Of Oxford ◽  
Esc Guidelines ◽  
European Society Of Cardiology

An engaging session on the newly revised European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) was conducted on the first day of the 2021 ESC virtual congress. Chaired by Colin Baigent, Professor of Epidemiology, University of Oxford, UK, the session also explored the classification and management of HF, and addressed questions from the congress audience.

Sign in / Sign up

Export Citation Format

Share Document